Annual ROA
-44.56%
-12.87%-40.61%
December 31, 2023
Summary
- As of February 7, 2025, GLUE annual return on assets is -44.56%, with the most recent change of -12.87% (-40.61%) on December 31, 2023.
- During the last 3 years, GLUE annual ROA has risen by +28.10% (+38.67%).
- GLUE annual ROA is now -120.70% below its all-time high of -20.19%, reached on December 31, 2021.
Performance
GLUE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-38.84%
+5.87%+13.13%
September 30, 2024
Summary
- As of February 7, 2025, GLUE quarterly return on assets is -38.84%, with the most recent change of +5.87% (+13.13%) on September 30, 2024.
- Over the past year, GLUE quarterly ROA has increased by +10.30% (+20.96%).
- GLUE quarterly ROA is now -70.65% below its all-time high of -22.76%, reached on December 31, 2021.
Performance
GLUE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
GLUE ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.6% | +21.0% |
| 3 y3 years | +38.7% | -26.3% |
| 5 y5 years | +36.1% | -26.3% |
GLUE ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -120.7% | at low | -70.7% | +21.0% |
| 5 y | 5-year | -120.7% | +38.7% | -70.7% | +46.5% |
| alltime | all time | -120.7% | +38.7% | -70.7% | +46.5% |
Monte Rosa Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -38.84%(-13.1%) |
| Jun 2024 | - | -44.71%(-9.0%) |
| Mar 2024 | - | -49.14%(+3.8%) |
| Dec 2023 | -44.56%(+40.6%) | -47.35%(+5.3%) |
| Sep 2023 | - | -44.96%(+15.5%) |
| Jun 2023 | - | -38.93%(+14.7%) |
| Mar 2023 | - | -33.94%(+10.3%) |
| Dec 2022 | -31.69% | -30.76%(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -28.20%(+10.0%) |
| Jun 2022 | - | -25.64%(+9.7%) |
| Mar 2022 | - | -23.37%(+2.7%) |
| Dec 2021 | -20.19%(-72.2%) | -22.76%(-20.3%) |
| Sep 2021 | - | -28.56%(+0.2%) |
| Jun 2021 | - | -28.50%(-25.3%) |
| Mar 2021 | - | -38.14%(-47.5%) |
| Dec 2020 | -72.66%(+4.1%) | -72.66% |
| Dec 2019 | -69.77% | - |
FAQ
- What is Monte Rosa Therapeutics annual return on assets?
- What is the all time high annual ROA for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual ROA year-on-year change?
- What is Monte Rosa Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly ROA year-on-year change?
What is Monte Rosa Therapeutics annual return on assets?
The current annual ROA of GLUE is -44.56%
What is the all time high annual ROA for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual return on assets is -20.19%
What is Monte Rosa Therapeutics annual ROA year-on-year change?
Over the past year, GLUE annual return on assets has changed by -12.87% (-40.61%)
What is Monte Rosa Therapeutics quarterly return on assets?
The current quarterly ROA of GLUE is -38.84%
What is the all time high quarterly ROA for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly return on assets is -22.76%
What is Monte Rosa Therapeutics quarterly ROA year-on-year change?
Over the past year, GLUE quarterly return on assets has changed by +10.30% (+20.96%)